Aion Therapeutic Inc.
ANTCF
$0.012
-$0.003-20.00%
| 01/31/2024 | 10/31/2023 | 07/31/2023 | 04/30/2023 | 01/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -49.04% | 1.73% | 64.22% | -233.81% | 66.75% |
| Total Depreciation and Amortization | -- | -- | -- | -97.67% | -2.27% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 50.64% | -1.67% | -94.97% | 778.29% | -117.19% |
| Change in Net Operating Assets | 573.62% | -1.76% | -63.49% | 25.15% | 80.71% |
| Cash from Operations | 275.12% | 1.72% | -193.57% | 225.87% | -1,581.67% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -100.00% | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 82.35% | 1.71% | -- | -- | -- |
| Cash from Investing | 82.35% | 1.71% | -- | -100.00% | -- |
| Total Debt Issued | -- | -- | -- | -94.57% | -76.77% |
| Total Debt Repaid | -- | -- | -- | 99.93% | -2,114.06% |
| Issuance of Common Stock | -100.00% | 0.00% | -- | -- | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -81.92% | -1.77% | 33,783.33% | 100.66% | -170.44% |
| Foreign Exchange rate Adjustments | 4,446.15% | 0.00% | 101.16% | -260.43% | 150.54% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 128,900.00% | 0.00% | 0.00% | 102.00% | -284.62% |
